Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Not Confirmed
Not Confirmed
21-22 January, 2026
Not Confirmed
Not Confirmed
27-29 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Industry Trade Show
Not Confirmed
21-22 January, 2026
Industry Trade Show
Not Confirmed
27-29 January, 2026
Digital content

13 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/13/3218287/0/en/Praxis-Precision-Medicines-Appoints-Global-Epilepsy-Leader-Dr-Orrin-Devinsky-as-Head-of-Clinical-Strategy.html

09 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/09/3216340/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

29 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/29/3210888/0/en/Praxis-Precision-Medicines-Announces-the-FDA-Has-Granted-Breakthrough-Therapy-Designation-for-Ulixacaltamide-HCl-in-Essential-Tremor.html

11 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/11/3203828/0/en/Praxis-Precision-Medicines-Announces-Plans-to-File-an-NDA-for-Relutrigine-in-SCN2A-and-SCN8A-Developmental-and-Epileptic-Encephalopathies-in-Early-2026.html

09 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/09/3202764/0/en/Praxis-Precision-Medicines-Announces-Alignment-with-FDA-on-Simplified-and-Accelerated-Registrational-Pathway-for-Elsunersen-in-Early-Onset-SCN2A-Developmental-and-Epileptic-Encepha.html

08 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/08/3201478/0/en/Praxis-AES-Wrap-up-Best-in-Class-Potential-Across-Rare-Pediatric-and-Adult-Epilepsies.html
ABOUT THIS PAGE